1 The EIC Accelerator Project

The EIC Accelerator program is a pivotal initiative under the European Innovation Council (EIC) designed to support small and medium-sized enterprises (SMEs) and startups in Europe, particularly those involved in deep technology and innovative solutions. The program aims to foster the development and scaling of groundbreaking ideas that can address substantial societal challenges. With a focus on high-risk, high-potential projects, the EIC Accelerator provides a unique blend of financial support, mentorship, and access to a vast network of investors and partners.

Funding under the EIC Accelerator consists of two key components: grants and equity investments. The grant component can reach up to €2.5 million, providing essential non-dilutive funding to cover the costs associated with innovation and development. This initial grant phase allows companies to validate their concepts and prototype solutions without the immediate pressure of equity dilution.

In addition to the grant, the EIC Accelerator offers equity investments of up to €15 million until 2024, which will be reduced to a maximum of €10 million starting in 2025. This equity funding serves as a crucial lifeline for startups, enabling them to scale operations, expand market reach, and enhance product development. The dual funding structure is designed to ensure that innovative companies can access both immediate financial support and longer-term investment, facilitating growth and sustainability in competitive markets.

The EIC Accelerator plays a vital role in the European DeepTech and startup ecosystem by bridging the gap between early-stage innovations and market-ready solutions. By providing substantial funding and tailored support, it encourages entrepreneurs to pursue ambitious projects that might otherwise struggle to secure financing in traditional investment environments. The program also emphasizes the importance of private sector collaboration, helping companies attract additional funding from venture capitalists and other investors.

A notable winner of the EIC Accelerator is BrainCapture, a Danish company recognized for its innovative project titled EDISON, which stands for EEG-based DIagnosis Support solutiON. The project aims to address the significant epilepsy diagnosis gap in Low- and Middle-Income Countries (LMICs) by leveraging an affordable, AI-guided electroencephalography (EEG) solution combined with telemedicine capabilities.

BrainCapture's EDISON project seeks to revolutionize the diagnosis of epilepsy, a condition that affects millions worldwide but is often underdiagnosed, particularly in disadvantaged regions. Traditional EEG technology can be expensive and complex, making it inaccessible to many healthcare providers in LMICs. EDISON addresses this challenge by developing a low capital expenditure (CAPEX) EEG solution that utilizes artificial intelligence to enhance diagnostic accuracy and streamline the assessment process.

The technology behind EDISON integrates advanced signal processing and machine learning algorithms to analyze EEG data. By employing AI, the system can identify patterns indicative of epileptic activity with improved speed and precision. This not only accelerates the diagnosis process but also empowers healthcare professionals in resource-limited settings to make informed decisions regarding patient care.

Furthermore, the integration of telemedicine within the EDISON project expands its reach, enabling remote consultations and support for healthcare practitioners. This is particularly crucial in areas where access to specialized neurological services is limited. By facilitating real-time communication and data sharing between patients and healthcare providers, EDISON enhances the overall diagnostic process and improves patient outcomes.

In summary, the EIC Accelerator program serves as a cornerstone of support for innovative startups like BrainCapture, enabling them to develop and scale transformative solutions in the healthcare sector. The combination of grant funding and equity investment empowers companies to address pressing challenges, such as the epilepsy diagnosis gap, through innovative technologies like EDISON. As the EIC Accelerator continues to foster deep tech innovations, it plays an essential role in enhancing the European startup ecosystem and driving forward impactful solutions that benefit society as a whole.

2 The Funding Rounds

BrainCapture (Denmark) – Financing and Funding Overview Since EIC Accelerator (2021-10-06)

Financing Raised

BrainCapture, a Danish medtech startup focused on affordable EEG diagnostics, has raised approximately $4 million in total funding to date. This includes both grants and equity investments.

Funding Rounds: Timing, Amounts & Investor Information

• Eurostars Grant (2020): Awarded €1 million from the Eurostars program to support early product development and validation.
• Seed Capital Round (2021): Raised €500,000 in seed funding from private investors. The identities of all individual investors have not been broadly disclosed, but the round included notable early-stage backers.
• EIC Accelerator Grant (2022): Secured €2 million as a non-dilutive grant from the European Innovation Council's Accelerator program following their successful application in October 2021. Alongside this grant comes an additional potential equity investment of up to €3.5 million by EIC, which is contingent on matching funds from qualified private investors.
• Private Equity Investments: As of April 2024, BrainCapture had received around $850,000 in equity investments beyond its grants—this figure likely overlaps with or follows earlier seed rounds but further investor details are limited publicly.

Additional smaller grants have come from organizations such as: - Epilepsy Foundation ($50K),

• Innowwide (€65K),
• Roddenberry Foundation ($15K),

to support international pilots and scale-up activities in markets like Kenya and the Philippines.

The Verge HealthTech Fund appears linked with recent activities as per September 2024 listings; specific investment amounts remain undisclosed but reinforce ongoing interest from health-focused venture capital sources.

Summary Table: Funding Timeline

Date	Source/Type	Amount	Notes
2020	Eurostars Grant	€1M	EU innovation grant
2021	Seed Capital	€500K	Private investors
Oct–Dec 2022	EIC Accelerator Grant+Equity Option	€2M (+€3.5M option)	Non-dilutive grant + potential matched equity
Ongoing	Additional Grants	~$130K	Epilepsy Found., Innowwide/Roddenberry
Sep 2024	Verge HealthTech Fund†                                                                                                                 Unknown VC participation indicated

*EIC process initiated October 6th, finalized by late 2022. †Verge HealthTech Fund noted as recent investor but amount not specified.

Company Valuation

Publicly available sources do not disclose explicit valuation figures for BrainCapture after its latest funding rounds. Given standard pre-seed/seed stage valuations for startups working with deep tech medical devices across Europe—and corresponding reported fundraising—the implied company valuation post-EIC round likely falls within typical ranges for companies at this stage (€7–15 million), though no official figure is confirmed by company or third-party databases reviewed here.

Exit Events: IPOs or Acquisitions

As of April 23rd, 2025:

• There are no public records indicating that BrainCapture has undergone an IPO.
• No acquisition or buyout activity involving BrainCapture has been reported.

The company remains privately held and continues to raise funds through a combination of grants and private capital aimed at scaling production and market reach across emerging economies.

---

Sources

• BrainCapture's BC-1 Solution - MIT Solve
• BrainCapture Company Information – The Hub
• Jalisco PlaiMX – BrainCapture Company Info
• Dealroom – BrainCapture Profile
• CB Insights – BrainCapture Financials
• Seedtable – Denmark Startups: BrainCapture DK Profile

3 The Press Releases

BrainCapture: Innovations and Developments Since EIC Accelerator Funding

BrainCapture, a Danish company and winner of the EIC Accelerator funding, has been at the forefront of innovative neurological diagnostics since receiving the award on October 6, 2021. This funding has significantly propelled the company's development and deployment of its flagship product, the BC-1 device, a low-cost, portable EEG system designed to enhance neurological diagnostics in underserved communities worldwide.

Technology Advancements

• Portable EEG Device (BC-1): The BC-1 device is designed to be user-friendly for non-EEG skilled personnel, making it highly recommendable for clinical use. It features high-quality signal capture and integrates well with a cloud-based platform for remote diagnosis and collaboration.
• AI Integration: BrainCapture incorporates advanced AI algorithms to enhance diagnostic accuracy and provide real-time feedback, improving the speed and accuracy of neurological assessments.
• Quality Control Algorithm: Development of a quality control algorithm to ensure better data quality from inexperienced operators, aligning with the need for reliable diagnostics in low-resource settings.

Partnerships and Collaborations

BrainCapture has collaborated with various institutions and experts to validate its technology, including the Technical University of Denmark (DTU), Harvard Medical School, and local healthcare providers in Kenya. These partnerships have been crucial in refining the BC-1 device and expanding its reach to underserved communities.

Funding and Recognition

• EIC Accelerator Funding: Received DKK 40 million (approximately €5.4 million) from the European Innovation Council Accelerator, alongside support from private investors. This funding is pivotal for commercializing the BC-1 device and ensuring its regulatory approvals in Europe and Africa.
• Recognition and Impact: BrainCapture's work has been recognized for its potential to bridge the diagnostic gap in neurological disorders, particularly epilepsy, in low- and middle-income countries. The company's approach enables local healthcare workers to perform EEG tests independently, reducing reliance on scarce neurological specialists.

Patents and Intellectual Property

BrainCapture has patented its innovative low-cost, portable EEG device, marking a significant milestone in the company's intellectual property portfolio. This development represents the first patent from BrainCapture, highlighting its commitment to advancing neurological diagnostics through accessible and affordable technology.

Website and Updates

BrainCapture's official website (www.braincapture.dk) provides comprehensive information on its products, mission, and collaborations. It details the features of the BC-1 device, user testimonials, and the company's vision for expanding neurological care through technology and partnerships.

Social Media and Press Releases

While specific social media updates from BrainCapture are not detailed in the available data, the company's website and press releases highlight its advancements and partnerships, showcasing its commitment to innovation in neurological diagnostics.

Sources

• Brain Products Press Release
• April 2025 - Brain Products Press Release
• Braincapture system enables remote diagnosis of epilepsy
• Home | BrainCapture - A Revolution in EEG
• BrainCapture's BC-1 Solution - MIT Solve
• EU support for low-cost medical equipment for epilepsy
• Low‐cost portable EEG device for bridging the diagnostic gap in ...
• AI from DTU to help diagnose epilepsy

4 The Technology Advancements

BrainCapture: Current Capabilities and Recent Advancements

BrainCapture, a Danish startup, is revolutionizing neurological diagnostics with its innovative EEG technology. Since receiving the EIC Accelerator funding in October 2021, the company has made significant strides in enhancing its technology and expanding its reach.

Current Capabilities

BrainCapture's flagship product, the BC-1, is an affordable, portable EEG device designed to improve neurological diagnostics in underserved communities worldwide. The BC-1 is easy to use, even for non-specialists, and integrates AI for enhanced diagnostic accuracy. It utilizes a cloud-based telemedicine platform, allowing local healthcare workers to connect with specialists for remote diagnostics and patient management.

Advancements Since EIC Funding

Following the EIC funding, BrainCapture received an additional DKK 40 million (approximately €5.4 million) from the EU's innovation fund and private investors in January 2022. This support has been crucial for refining the prototype and preparing it for market entry.

The company has focused on developing a quality control algorithm to ensure better diagnostics. This algorithm is nearing completion and will be tested on BrainCapture's device to enhance data quality for inexperienced operators.

Technology Improvements

BrainCapture has continued to enhance its technology by integrating advanced AI algorithms to improve diagnostic accuracy and provide real-time feedback. The BC-1 device includes a smartphone application and quality control algorithm, allowing non-expert workers to collect high-quality EEG data with minimal training.

Market Demonstrations and Trials

BrainCapture has demonstrated its technology in various markets, including pilot programs in Kenya, where local health workers effectively used the BC-1 after minimal training, significantly increasing the number of patients screened for epilepsy and other neurological conditions. The company has also collaborated with local doctors in Kenya for further testing and rollout.

New Patents and Publications

There is no specific information available on new patents filed by BrainCapture since the EIC funding. However, the company continues to innovate and validate its technology through usability testing and trials across different regions.

Sources

• BrainCapture's BC-1 Solution - MIT Solve
• Home | BrainCapture - A Revolution in EEG
• BrainCapture – Low-cost Mobile EEG For Epilepsy Detection
• EU support for low-cost medical equipment for epilepsy - DTU
• BrainCapture - The Hub
• Announcements - Wellesta | Value Added Partner for Healthcare

5 The Partnerships and Customers

BrainCapture: Partnerships and Advancements

BrainCapture, a Danish company and EIC Accelerator winner, has been making significant strides in the medical technology sector, particularly with its innovative EEG device, the BC-1. This device is designed to enhance neurological diagnostics in underserved communities worldwide.

Partnerships

BrainCapture has established a notable partnership with Wellesta, a healthcare company based in Singapore. This collaboration began with the goal of marketing and distributing BrainCapture's BC-1 in key markets. As of January 2025, the partnership expanded to include distribution in Vietnam, Cambodia, Brunei, and Laos, further increasing access to neurodiagnostic tools in Southeast Asia.

Another significant development is BrainCapture's involvement in the MIT Solve's Global Health Challenge, which highlights the company's commitment to scaling its technology and improving neurological care in resource-limited settings.

New Partners

While specific new partners beyond Wellesta have not been detailed, BrainCapture's expansion into additional markets and participation in global health challenges indicate a growing network of collaborations that align with its mission of democratizing EEG access.

Customers and Purpose of Relationships

BrainCapture's primary focus is on providing affordable, portable EEG solutions, especially in underserved communities. The company aims to empower local healthcare workers by training them to use the BC-1 effectively, ensuring rapid turnaround times for diagnostic results, and leveraging cloud-based telemedicine platforms for remote consultations. The purpose of these relationships is to enhance access to neurological diagnostics, improve diagnostic accuracy and speed, and empower local health workers to perform diagnostics independently.

Market Positioning and Advancements

The partnerships and collaborations will position BrainCapture as a leader in accessible neurodiagnostic technology. By expanding its market reach and integrating its solutions with existing healthcare systems, BrainCapture can enhance its competitive edge in the medical technology sector. Technological advancements, such as AI integrations and cloud-based analyses, will help BrainCapture scale its operations efficiently and maintain a high standard of diagnostic accuracy and speed. The dual revenue streams from device sales and telemedicine services will further incentivize distributors to support the deployment and maintenance of the BC-1.

Scaling and Technology Advancements

BrainCapture's technology advancements are driven by its focus on scalability and accessibility. The BC-1's integration with AI algorithms and cloud-based platforms allows for real-time feedback and enhanced diagnostic accuracy. This not only improves the efficiency of neurological diagnostics but also supports the collection and harmonization of EEG datasets for better monitoring and management of neurological disorders. As BrainCapture continues to expand its partnerships, it is poised to accelerate the adoption of its innovative EEG solutions across diverse markets.

Sources: - Announcements - Wellesta

• BrainCapture's BC-1 Solution - MIT Solve
• Announcements - Wellesta

6 The Hiring and Company Growth

BrainCapture, a Danish med-tech startup founded in 2019 and headquartered in Kongens Lyngby, Denmark, has experienced steady team growth since receiving the European Innovation Council (EIC) Accelerator funding in late 2022. The company develops an affordable, portable EEG device (BC-1) aimed at improving neurological diagnostics access in emerging markets.

Team Size and Growth

• As of recent data, BrainCapture's team size is estimated to be between 1 to 10 employees. Although small by absolute numbers, this core team includes key leadership such as CEO Tue Lehn-Schiøler, CTO Radu Gâtej, and Head of Business Development Paul Loomis.
• Since winning the EIC Accelerator funding (€2 million awarded in 2022), BrainCapture has been actively expanding their workforce with several new profiles to scale up development and deployment efforts through at least 2025.

Hiring Activity

• BrainCapture is currently expanding its team with a focus on diversifying talent from regions where they operate or plan to operate. For example:
• They are building marketing and tech support teams in countries like the Philippines through local partnerships.
• Their recruitment strategy emphasizes diversity and inclusion aligned with their global mission.
• The company’s ongoing hiring supports operational scaling as they prepare for broader market rollouts across Africa and Asia.

Key Recent Hires & Team Composition

• While specific recent hires are not itemized publicly, the founding core combines AI experts from DTU Technical University of Denmark alongside neurologists affiliated with Harvard Medical School. This interdisciplinary mix is critical for product innovation combining AI automation with clinical expertise.
• Leadership includes individuals such as Dr. Farrah Mateen who brings extensive neurological care experience globally—highlighting a strategic focus on cultural competence within management.

Impact of New Team Members

• New hires strengthen BrainCapture’s ability to finalize device development milestones and enhance telemedicine services enabling up to 80–120 EEG tests per month currently.
• Expanding teams enable faster scaling into new countries (3–4 annually projected over five years), aiming to serve over one million patients by leveraging revenues from hardware sales plus telemedicine services by around 2028.
• The growing workforce supports evolving revenue streams including data analytics collaborations targeting research institutions and pharmaceutical companies—indicating an ambition beyond hardware sales into service-based models that require diverse skillsets including software development, customer support, regulatory affairs, etc.

Management Changes

There are no public reports indicating major changes or upheavals within BrainCapture’s founding or executive management since obtaining EIC funding. The leadership remains stable under CEO Tue Lehn-Schiøler supported by experienced technical co-founders.

---

In summary:

Aspect	Details
Current Team Size	Approximately 1–10 employees
Hiring Status	Actively hiring; expanding marketing/tech support teams internationally
Growth Since EIC Funding	Secured €2M EIC grant; scaling operations through end of 2025; preparing multi-country expansion
Key Roles Recently Added	Not specified individually but include technical developers & regional marketing/support staff
Future Impact of Hiring	Enables product delivery at scale; expanding telemedicine capacity; broadening revenue diversification
Management Stability	No major changes reported post-EIC funding

BrainCapture’s deliberate approach towards recruitment focusing on diversity from target regions enhances their ability to understand local needs while scaling technologically sophisticated solutions globally. This positions them well for sustained growth as they commercialize their BC-1 system across multiple emerging markets.

Sources:

7 The Media Features and Publications

BrainCapture, a Danish startup that won the EIC Accelerator funding in October 2021, has garnered notable media attention and participation in various events related to its innovative EEG technology designed to improve neurological diagnostics globally.

Media Features and Publications

BrainCapture has been prominently featured in multiple specialized publications highlighting its affordable, mobile EEG device aimed at enhancing epilepsy detection and neurological care access in low-resource settings. Key media mentions include:

• BioWorld detailed BrainCapture's BC-1 system enabling remote diagnosis of epilepsy through a cloud-based telemedicine platform that transmits EEG data from the device via a smartphone app for expert analysis.
• Consonance.tech described BrainCapture’s portable Bluetooth-enabled EEG amplifier and cap system which aims to provide accessible neurological testing especially across Africa, the Middle East, and Asia—regions with limited access to traditional expensive EEG services.
• Wolfpack Digital, involved in developing BrainCapture’s mobile app software, presented how their collaboration created an IEC 62304-compliant app facilitating offline Bluetooth data transmission from amplifier to smartphone for affordable EEG scans.
• The official company website emphasizes the ease of use by non-specialists after short training sessions, cloud-based centralized diagnostic platform extending expertise reach globally, and strong endorsements by clinical neurologists appreciating its usability and signal quality.
• Health Tech Hub Copenhagen featured BrainCapture as a promising health tech startup focusing on AI-enabled affordable healthcare delivering neurological diagnostics as a service worldwide.
• MIT Solve highlighted BrainCapture’s scalable cloud-based telemedicine approach enabling rapid turnaround (within 2 hours) of diagnostic results through trained local healthcare workers empowered by AI algorithms. This model addresses critical gaps in underserved communities’ access to neurological care.

Podcasts or Interviews

There is no direct evidence from available sources indicating that BrainCapture's team members have participated specifically in podcasts or interviews under their company name. However:

There exist podcasts like "Brain Beat" by BrainWise Media covering brain health topics broadly but no explicit mention of BrainCapture representatives being guests was found within current search results.

No other podcast or interview appearances directly featuring the company's leadership were identified.

Conferences, Fairs & Presentations

While specific conference participations directly attributed to BrainCapture post-EIC funding are not explicitly documented among search results:

The company operates within fields overlapping major neuroscience programs such as international brain science initiatives discussed at Keystone meetings; however these are general neuroscience gatherings without direct mention of BrainCapture participation.

There is no public record found on presentations or fair visits officially done by BrainCapture since receiving EIC funding.

Involvement in Events

No concrete details were found about active event sponsorships or organizational involvements undertaken by BrainCapture following their EIC Accelerator success.

---

In summary, since winning the EIC Accelerator grant on October 6th, 2021, BrainCapture has been featured extensively across medical technology news outlets emphasizing its portable low-cost EEG solution for epilepsy diagnosis using Bluetooth connectivity paired with smartphone apps and cloud telemedicine platforms. It enjoys recognition among clinicians for increasing accessibility of neurodiagnostics worldwide but lacks publicly documented podcast appearances or recorded conference participations directly tied to their team during this period.

Sources

• Braincapture system enables remote diagnosis of epilepsy - BioWorld
• Brain Capture – Low-cost Mobile EEG For Epilepsy Detection - Consonance
• Brain Capture - affordable EEG scans - Wolfpack Digital
• Home | Brain Capture official site
• Meet Branccapture - Health Tech Hub Copenhagen
• Brain Capture's BC‑1 Solution - MIT Solve